EN
抗体药类似物
Research Grade Cevostamab
All
TD-HV698016_1.jpg
TD-HV698016_2.jpg
  • CatalogTD-HV698016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsBispecific,BFCR-4350-A,BFCR-4350A,RG-6160,RO-7187797,CAS:2249888-53-5
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Cevostamab


Catalog No. TD-HV698016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target FcRL5, FCRH5, FCRL5, Fc receptor homolog 5, FcRH5, CD307e, FcR-like protein 5, IRTA2, Immune receptor translocation-associated protein 2, BXMAS1, Fc receptor-like protein 5, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession Q96RD9 & P07766
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names Bispecific,BFCR-4350-A,BFCR-4350A,RG-6160,RO-7187797,CAS:2249888-53-5
Background Cevostamab (BFCR4350A; RG6160; RO7187797) is a humanized IgG1-based BsAb that targets membrane-proximal extracellular domain of FcRH5 on multiple myeloma (MM) cells as well as CD3 on T cells. Moreover, Cevostamab facilitates efficient synapse formation, improves killing activity of T cells against MM tumor cells.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HV698016_1.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Cevostamab
TD-HV698016_2.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Cevostamab.